Differential Expression of RSK4 Transcript Isoforms in Cancer and Its Clinical Relevance
While we previously revealed RSK4 as a therapeutic target in lung and bladder cancers, the wider role of this kinase in other cancers remains controversial. Indeed, other reports instead proposed RSK4 as a tumour suppressor in colorectal and gastric cancers and are contradictory in breast malignanci...
Main Authors: | Sisi Chen, Michael J. Seckl, Marc P. G. Lorentzen, Olivier E. Pardo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/23/14569 |
Similar Items
-
RSK Isoforms in Acute Myeloid Leukemia
by: Minyoung Youn, et al.
Published: (2021-06-01) -
Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses
by: Shasha Wu, et al.
Published: (2023-12-01) -
Identifying requirements for RSK2 specific inhibitors
by: Eric B. Wright, et al.
Published: (2021-01-01) -
Updating mRNA variants of the human RSK4 gene and their expression in different stressed situations
by: Zhenwei Qin, et al.
Published: (2024-04-01) -
A Novel Protein–Protein Interaction between RSK3 and IκBα and a New Binding Inhibitor That Suppresses Breast Cancer Tumorigenesis
by: Hee-Sub Yoon, et al.
Published: (2021-06-01)